GGrantIndex
Sort

23,748 grants matching melanoma

Role of ADAM9 in viral RNA sensing and antiviral innate immunity

$265,232
Evelyn A. Kurt-Jones · Univ Of Massachusetts Med Sch Worcester · R21 · FY2023 · AI

Optimization of Melanoma Vaccine with T Helper Epitope

$265,220
University Of Pittsburgh At Pittsburgh · R01 · FY2003 · CA

IDENTIFICATION OF CD8+ T CELL TARGETS ON RENAL CANCER

$265,203
Johns Hopkins University · R01 · FY2001 · CA

QUALITY OF LIFE--THE COLLABORATIVE OCULAR MELANOMA STUDY

$265,182
Johns Hopkins University · U10 · FY2000 · EY

Correlating Environmental & Genetic Risk Factors with Molecular Signatures in

$265,135
David John Hunter · Brigham And Women'S Hospital · P50 · FY2012 · CA

Multi-Peptide/IL 12 Melanoma Vaccine

$265,071
Thomas F Gajewski · University Of Chicago · R01 · FY2006 · CA

HUMAN

$265,042
Ellen L Jones · Duke University · P01 · FY2009 · CA

Metastatic protein network in BRAFV600E positive human thyroid cancers

$264,915
Carmelo Nucera · Beth Israel Deaconess Medical Center · R21 · FY2012 · CA

Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC

$264,902
James P Allison · University Of Tx Md Anderson Can Ctr · P50 · FY2017 · CA

Polarization of Dendritic Cells by CD8 T cells

$264,893
University Of Pittsburgh At Pittsburgh · R01 · FY2003 · CA

Regulation of Cytokine Gene Expression by mRNA Turnover

$264,890
Univ Of Med/Dent Nj-R W Johnson Med Sch · P01 · FY2005 · AI

ECM MATRIX, PROTEASE AND MELANOMA PROLIFERATION

$264,864
Children'S Hospital Los Angeles · R01 · FY2003 · CA

ECM MATRIX, PROTEASE AND MELANOMA PROLIFERATION

$264,864
Children'S Hospital Los Angeles · R01 · FY2005 · CA

ECM MATRIX, PROTEASE AND MELANOMA PROLIFERATION

$264,864
Children'S Hospital Los Angeles · R01 · FY2004 · CA

Integrin-mediated regulation of type-1 dendritic cell positioning and function in lymph nodes

$264,750
Michael Gerner · University Of Washington · R21 · FY2025 · AI

Role of IKK in NSCLC Modulation of SMRT and NF-kappab

$264,732
Marty W Mayo · University Of Virginia · R01 · FY2007 · CA

Role of IKK in NSCLC Modulation of SMRT and NF-kappab

$264,670
Marty W Mayo · University Of Virginia · R01 · FY2008 · CA

ABCB5 and Melanoma Stem Cells: Implications for Prognosis & Therapeutic Targeting

$264,624
Frank Markus · Brigham And Women'S Hospital · P50 · FY2011 · CA

ANALYSIS OF CD8 T CELL RESPONSES TO TUMORS

$264,600
Trudeau Institute, Inc. · R01 · FY2000 · CA

MECHANISM OF ACTIN-BASED CELL MOTILITY

$264,600
Northwestern University · R01 · FY2001 · GM

MECHANISM OF ACTIN-BASED CELL MOTILITY

$264,600
Northwestern University · R01 · FY2004 · GM

MECHANISM OF ACTIN-BASED CELL MOTILITY

$264,600
Northwestern University · R01 · FY2002 · GM

Phase 2 Study of Anti Vegf Antibody in Melanoma

$264,600
Ohio State University · R21 · FY2001 · CA

MECHANISM OF ACTIN-BASED CELL MOTILITY

$264,600
Northwestern University · R01 · FY2003 · GM

Dendritic Cell Strategies to Tumor Reactive T Cells

$264,591
University Of Pittsburgh At Pittsburgh · R01 · FY2005 · CA